Skip to main content
Clinical Trials/NCT00773123
NCT00773123UnknownNot Applicable

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

Yonsei University1 site in 1 country300 target enrollmentStarted: October 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
300
Locations
1
Primary Endpoint
Ganglion cell layer thickness

Study Overview

Brief Summary

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion cell layer thickness.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
10 Years to 90 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Evidence of retinal disease
  • Neovascular glaucoma
  • Secondary glaucoma due to intraocular inflammation
  • Lens induced glaucoma
  • Tumor induced glaucoma

Outcomes

Primary Outcomes

Ganglion cell layer thickness

Time Frame: 1 month

Secondary Outcomes

  • Visual field defect(1 month)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Efficacy of Retinal Nerve Fiber Layer... | Clinical Trial